Keith Parent

Keith Parent founded Court Square Group in January 1995 and has been the company’s CEO since inception. Under Keith’s leadership Court Square Group has built a reputation as an industry leader in the Life Sciences industry. With over 35 years of technology and leadership experience in the Life Science industry, Keith has a clear understanding of regulatory challenges and the Good System Practices (GSPs) required to maintain a Qualified state for the company’s clients.

Keith holds a Master of Science in Computer Science (MSCS) from Rensselaer Polytechnic Institute and a Bachelor of Science in Computer Science from Siena College. Keith has been involved in the implementation and maintenance of enterprise-level systems across the pre-clinical and clinical organizations of numerous Life Science clients. Under Keith’s direction Court Square has managed over 5,000 servers world-wide for their Life Science clients, including CTMS systems, Global Submission systems, eCTD systems, FDA Gateways, Adverse Event Reporting systems, as well as numerous Clinical Trial systems and Longitudinal Patient Registry development systems with responsibility for over 100,000+ users in various clinical settings.

As a Co- Founder and Advisor at EmpiraMed, the company has developed a patient engagement software platform called the PRO Portal to capture electronic patient-reported outcomes (ePRO) to better measure what works and what doesn’t work in the real world. EmpiraMed’s unique rules-based approach completely automates all patient interactions via the web and any mobile device while seamlessly integrating healthcare personnel patient recruitment and follow-up to execute studies or programs in less time, at lower cost, and with greater flexibility.

As a Co- Founder and Partner at RegDocs365, a powerful suite of tools were developed to enable Life Science startup companies and CROs to have tools only available to Fortune 100 clients. By enabling a Life Science Startup kit, RegDocs365 enables clients to have a qualified environment to enable them to submit to the FDA utilizing the DIA EDM and eTMF reference models without having to worry about the regulatory compliance aspects since given everything is housed within the CSG ARCC environment. Also, the future of clinical trials is taking shape with the CRO Voice and Video Workbench available to utilize off-the-shelf conferencing tools to capture patient and clinician information while providing a 21 CFR Part 11 wrapper around the gathered data.

Keith has been a consultant to Pfizer Pharmaceutical for over 27 years and has held other leadership positions in the Life Science Industry. He is a regular guest speaker at many Life Science events and a thought leader for companies that are building solutions in the Life Science Industry.